His main research concerns Surgery, Angioplasty, Restenosis, Stent and Randomized controlled trial. Surgery is frequently linked to Radiology in his study. His studies deal with areas such as Lesion, Multicenter trial, Amputation, Revascularization and Aortic stent as well as Angioplasty.
His studies in Restenosis integrate themes in fields like Contrast medium, Stenosis, Vascular disease and Target lesion. His Drug-eluting stent study in the realm of Stent interacts with subjects such as False lumen. While the research belongs to areas of Randomized controlled trial, Thomas Zeller spends his time largely on the problem of Blood pressure, intersecting his research to questions surrounding Ambulatory, Catheter, Intensive care medicine and Kidney.
His scientific interests lie mostly in Surgery, Angioplasty, Radiology, Stent and Restenosis. His research combines Revascularization and Surgery. His Angioplasty study integrates concerns from other disciplines, such as Lesion, Critical limb ischemia and Femoral artery.
Thomas Zeller specializes in Stent, namely Drug-eluting stent. His research integrates issues of Prospective cohort study, Claudication, Clinical endpoint and Vascular Patency in his study of Restenosis. His biological study deals with issues like Denervation, which deal with fields such as Catheter.
Thomas Zeller focuses on Surgery, Angioplasty, Balloon, Randomized controlled trial and Stent. His Surgery research includes themes of Adverse effect, Clinical trial and Revascularization. His Angioplasty study incorporates themes from Drug coated balloon, Restenosis, Intermittent claudication and Lesion.
He has researched Balloon in several fields, including Sirolimus, Artery, Excipient and Paclitaxel coated balloon. Thomas Zeller has included themes like Percutaneous and Incidence in his Randomized controlled trial study. His Stent study is related to the wider topic of Radiology.
The scientist’s investigation covers issues in Surgery, Randomized controlled trial, Angioplasty, Balloon and Adverse effect. His Popliteal artery, Stent and Critical limb ischemia study in the realm of Surgery connects with subjects such as Target lesion revascularization. His research in Randomized controlled trial intersects with topics in Restenosis, Percutaneous and Arterial disease.
His Angioplasty research is multidisciplinary, relying on both Intermittent claudication, Stenosis and Amputation. The study incorporates disciplines such as Meta-analysis, Clinical trial and Revascularization in addition to Balloon. His Adverse effect research integrates issues from Peripheral, Anesthesia, Blood pressure and Denervation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial
Murray D. Esler;Henry Krum;Paul A. Sobotka;Markus P. Schlaich.
The Lancet (2010)
Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg.
Gunnar Tepe;Thomas Zeller;Thomas Albrecht;Stephan Heller.
The New England Journal of Medicine (2008)
Nitinol Stent Implantation Versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length The Femoral Artery Stenting Trial (FAST)
Hans Krankenberg;Michael Schlüter;Hermann J. Steinkamp;Karlheinz Bürgelin.
Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial
Raymond R Townsend;Felix Mahfoud;Felix Mahfoud;David E Kandzari;Kazuomi Kario.
The Lancet (2017)
Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease 12-Month Results From the IN.PACT SFA Randomized Trial
Gunnar Tepe;John Laird;Peter Schneider;Marianne Brodmann.
Paclitaxel-Eluting Stents Show Superiority to Balloon Angioplasty and Bare Metal Stents in Femoropopliteal Disease Twelve-Month Zilver PTX Randomized Study Results
Michael D. Dake;Gary M. Ansel;Michael R. Jaff;Takao Ohki.
Circulation-cardiovascular Interventions (2011)
Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial
David E Kandzari;Michael Böhm;Felix Mahfoud;Felix Mahfoud;Raymond R Townsend.
The Lancet (2018)
Medial vascular calcification revisited: review and perspectives
Peter Lanzer;Manfred Boehm;Victor Sorribas;Marc Thiriet.
European Heart Journal (2014)
Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial.
Stephan H. Duda;Stephan H. Duda;Marc Bosiers;Johannes Lammer;Dierk Scheinert.
Journal of Endovascular Therapy (2006)
Expert consensus document from the European Society of Cardiology on catheter-based renal denervation
Felix Mahfoud;Thomas Felix Lüscher;Bert Andersson;Iris Baumgartner.
European Heart Journal (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: